ROBERTO
RODRÍGUEZ JIMÉNEZ
Profesor titular de universidad
![Foto de ROBERTO](/img/nophoto.png)
![Foto de Instituto de Investigación Sanitaria de Navarra](/img/noimage_org.png)
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (22)
2024
-
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
Schizophrenia Research, Vol. 267, pp. 24-31
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations
Schizophrenia Research, Vol. 267, pp. 534-545
2023
-
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients
Revista de Psiquiatria y Salud Mental
-
Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis
Acta Psychiatrica Scandinavica
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia
Schizophrenia Research, Vol. 243, pp. 32-42
-
Epigenetic clocks in relapse after a first episode of schizophrenia
Schizophrenia, Vol. 8, Núm. 1
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden
Schizophrenia Research, Vol. 248, pp. 331-340
-
Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance
Revista de Psiquiatria y Salud Mental
-
The network structure of cognitive deficits in first episode psychosis patients
Schizophrenia Research, Vol. 244, pp. 46-54
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Translational Psychiatry, Vol. 11, Núm. 1
2018
-
Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis
Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455
-
Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study
European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711
-
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256
-
Smoking does not impact social and non-social cognition in patients with first episode psychosis
Schizophrenia Research, Vol. 199, pp. 64-74
2017
-
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
European Neuropsychopharmacology, Vol. 27, Núm. 7, pp. 647-656